All In Biotech

Drug Trial Radar · NCT00525707

Tezosentan in Acute Heart Failure

Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel Group Study to Assess the Efficacy, Safety, and Tolerability of Tezosentan in Patients With Acute Heart Failure.

Last checked: Nov 20, 2026Latest source record: Jul 10, 2018 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingPhase 3. Randomized with 735 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

735

Actual

Start

Apr 2003

Primary completion

Jan 2005

Study completion Jan 2005

Sponsor

Lead sponsor
Idorsia Pharmaceuticals Ltd.Industry
Sponsor type
Industry
First posted
Sep 6, 2007

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The randomized patients with acute heart failure will be stratified based on the presence or absence of a Swan-Ganz catheter and assigned to receive either tezosentan 5 mg/h for the first 30 minutes and 1 mg/h thereafter or matching placebo in a 1:1 manner. The duration of the treatment is 24 hours up to 72 hours. The duration of the follow-up period is 30 days after treatment initiation for death, re-hospitalizations and SAEs followed by a follow-up period of 5 months for vital status.

Conditions

  • Acute Heart Failure
  • Acute Decompensation of Chronic Heart Failure
  • New Onset of Heart Failure

Interventions

  • tezosentanDrug

    tezosentan delivered i.v. at 20 mL/h (5 mg/h) for 30 min followed by 4ML/h (1 mg/h) for 23.5 to 71.5 h (24 to 72 h in total)

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Incidence of death or worsening heart failureTime frame: 7 days following study drug initiation

Locations

35 sites in 10 countries. Site status is shown where the registry gives one.

  • University of Alabama-Birmingham

    Birmingham, Alabama

  • Advanced Heart Failure and Transplant Service, Palo Alto VA Health Care System, Cardiology Section

    Palo Alto, California

  • Denver VAMC

    Denver, Colorado

  • The Heart Hospital at Alledgheny General, Division of Cardiology

    Pittsburgh, Pennsylvania

  • Veterans Affairs Medical Center

    Houston, Texas

  • Tyler Cardiovascular Consultants

    Tyler, Texas

  • Danville Medical Center

    Danville, Virginia

  • Medical Associates, Bellebue

    Bellevue, Washington

  • AKH University of Vienna, Abt. Medizinische Kardiologie

    Vienna, Austria

  • Roskilde Amt Sygehus

    Roskilde, Denmark

  • Hopital Ambroise Pare, Service de Cardiologie

    Boulogne, France

  • Heart Failure clinic C.H. Dubos

    Pontoise, France

  • Hopitaux Universitaires de Strasbourg, Hopital Hautepierre

    Strasbourg, France

  • CHU Rangueil, Cardiologie A

    Toulouse, France

  • Medizinische Klinik I, Universitatsklinikum Aachen

    Aachen, Germany

  • Campus Virchow-Klinikum, Medizinishe Klinik mit Schwerpunkt Kardiologie

    Berlin, Germany

  • Georg-August-Universitat Gottingen, Zentrum fur Innere Med

    Göttingen, Germany

  • Dept. of Cardiology, University of Athens, Alexandra Hospital

    Athens, Greece

  • Barzilai Hospital

    Ashkelon, Israel

  • Carmel Medical Center

    Haifa, Israel

  • Wolfson Medical Center

    Holon, Israel

  • Hadassah Hospital

    Jerusalem, Israel

  • Nazareth Hospital EMMS

    Nazareth, Israel

  • Assaf-Harofeh Medical Center

    Tsrifin, Israel

  • Klinika Kardiologii i Chorob Wewnetrznych, Samodzielny Publiczny Szpital

    Bydgoszcz, Poland

  • Klinika Chorob Serca, Akademia Medyczna w Gdansku

    Gdansk, Poland

  • I Klinika Kardiolgii, Collegium Medicum UJ

    Krakow, Poland

  • Institute of Cardiology College, College of Medicine of Jagellonian University

    Krakow, Poland

  • Kategra I Klinika Kardiolgii AM

    Wroclaw, Poland

  • Centre Hospitalier Universitaire Vaudois (CHUV)

    Lausanne, Switzerland

  • Cardio Centro Ticino, Servizio Cardiovasculare

    Lugano, Switzerland

  • University Hospital Zurich

    Zurich, Switzerland

  • Glasgow Royal Infirmary

    Glasgow, United Kingdom

  • Hull Royal Infirmary

    Hull, United Kingdom

  • Scunthorpe General Hospital

    Scunthorpe, United Kingdom

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.